Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Arthritic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02319759
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Janssen Research & Development, LLC 149
Not applicableStudy completedNCT07041112
What this trial is testing

Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

Who this might be right for
PsoriasisPsoriatic Arthritis (PsA)Cardiovascular Risk Factors+3 more
Juan Ruano Ruiz 1,000
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT07315061
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis

Who this might be right for
PsA (Psoriatic Arthritis)
InventisBio Co., Ltd 222
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Large-scale testing (Phase 3)Study completedNCT03370133
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 567
Not applicableUnknownNCT04429776
What this trial is testing

Tapering of Biologics in Inflammatory Arthritis Patients in Remission

Who this might be right for
Rheumatoid ArthritisPsoriatic Arthritis
University of Manchester 51
Not applicableUnknownNCT04821206
What this trial is testing

PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

Who this might be right for
Arthritis, RheumatoidArthritis, PsoriaticSpondyloarthritis
Liga Panamericana de Asociaciones de Reumatologia (PANLAR) 3,000
Not applicableEnded earlyNCT02841176
What this trial is testing

Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Imperial College Healthcare NHS Trust 4
Not applicableNot Yet RecruitingNCT07403890
What this trial is testing

Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
NHS Greater Glasgow and Clyde 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07744191
What this trial is testing

A Clinical Trial of Antiplatelets in Psoriasis

Who this might be right for
Psoriasis (PsO)Psoriatic Arthritis (PsA)
NYU Langone Health 60
Post-approval studies (Phase 4)Study completedNCT01147874
What this trial is testing

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Who this might be right for
PsoriasisPsoriatic Arthritis
Pfizer 1,013
Not applicableEnrolling By InvitationNCT07188285
What this trial is testing

Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErthematosusSjogren's SyndromeInflammatory Myopathies+8 more
Peking University People's Hospital 500
Post-approval studies (Phase 4)Study completedNCT02148640
What this trial is testing

The NOR-SWITCH Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisPsoriatic Arthritis+3 more
Diakonhjemmet Hospital 482
Not applicableNot Yet RecruitingNCT06790940
What this trial is testing

Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information

Who this might be right for
Psoriasis (PsO)Psoriatic ArthritisPalmoplantar Pustulosis (PPP)+1 more
Shanghai Yueyang Integrated Medicine Hospital 310
Not applicableStudy completedNCT03885089
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Who this might be right for
Psoriasis VulgarisPsoriasis ArthropathicaPustular Psoriasis+1 more
Pfizer 10
Testing effectiveness (Phase 2)Ended earlyNCT04269993
What this trial is testing

Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis

Who this might be right for
Rheumatoid ArthritisPsoriatic Arthritis
Brown University 3
Not applicableWithdrawnNCT04341233
What this trial is testing

Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis

Who this might be right for
Spondylitis, AnkylosingPsoriatic Arthritis
NHS Lothian
Not applicableWithdrawnNCT06431750
What this trial is testing

Prospective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT01392326
What this trial is testing

Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 606
Next Page